Quizartinib (Vanflyta®) has not been requested for formulary status and is not routinely stocked by sites due to the REMS program. The goal of the Vanflyta REMS is to mitigate the serious risk of QT prolongation, Torsades de Pointes and cardiac arrest, and includes health care provider, patient, pharmacy and wholesaler-distributor requirements for dispensing. See Legacy Health REMS Requirements for detail.
Add Formweb to your mobile device
Quizartinib (Vanflyta®) has not been requested for formulary status and is not routinely stocked by sites due to the REMS program. The goal of the Vanflyta REMS is to mitigate the serious risk of QT prolongation, Torsades de Pointes and cardiac arrest, and includes health care provider, patient, pharmacy and wholesaler-distributor requirements for dispensing. See Legacy Health REMS Requirements for detail.